Morning Overview on MSN

The FDA’s March warning linked carbidopa-levodopa drugs to B6 deficiency and associated seizures

The FDA has required stronger warnings that medicines containing carbidopa and levodopa can deplete vitamin B6 and, in rare severe cases, contribute to seizures. The combination remains a cornerstone ...
Morning Overview on MSN

The FDA now requires a seizure warning on a common Parkinson’s drug millions take

Since March 2026, drugmakers have been required to add a new warning to carbidopa/levodopa, the standard combination therapy for Parkinson’s disease symptoms, after the Food and Drug Administration ...
FiercePharma

AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease

DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease · In a clinical trial, patients treated with DUOPA ...
irblog.prnewswire.com

Impax Pharmaceuticals Announce FDA Approval of RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules for the Treatment of Parkinson's disease

HAYWARD, Calif., Jan. 8, 2015 /PRNewswire/ -- Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S. Food and Drug Administration (FDA) approved ...